Brochure More information from http://www.researchandmarkets.com/reports/2013905/

The CRO Market Outlook to 2016 Description:

This report examines CRO markets in the US, Eastern Europe, Western Europe, China, India, Other Asia, and Latin America. Leading players are profiled and compared according to capability. The report also maps out the the future of the industry through to 2016. Features and benefits: - Forecast the market size for contract research in the US, Eastern Europe, Western Europe, China, India, Other Asia, and Latin America. - Discover the opportunities presented by emerging CRO markets and optimize your research sourcing strategies. - Understand how CRO utilization is evolving, and what the future of the industry is. - Assess the growth potential of the industry and understand how leading players are taking advantage of the opportunities in this market. - Compare and contrast capabilities of leading CROs in each region and identify potential partners or rivals. Highlights: - New economic challenges coming to light in 2011 will further pressure the industry, making drug maker financial performance even more important and tightening access to capital for smaller players. - A variety of factors are fueling strong and continued increases in CRO usage including vertical integration, risk sharing programs, overall growth of R&D spending, biotech expansion, adaptive trials, and technology such as ePRO. - In 2012 and 2013, economic and industry pressures will have the net effect of reducing overall drug development activity, particularly R&D conducted in-house. Although contract services will also be affected, they will continue to be considered more attractive, with a higher cost-benefit ratio than in-house drug development. Your key questions answered: - What factors are underpinning the growth of the CRO market? - Why is M&A activity of CROs high and why will this continue? - How is demand for different types of CRO services changing? - Which are the leading CROs in each region and why? - What regions will experience the greatest growth of CRO activity and how can drug developers optimize their work with CROs in these areas?

Contents:

EXECUTIVE SUMMARY The shifting R&D landscape The continued growth of contract R&D Continued demand in the established regions Strong growth in the emerging regions Leading global CROs and best practices The future of contract research The shifting R&D landscape Summary Introduction The drug approval process US Europe Rising pressures on established and emerging drug makers Blockbuster patent expirations and genericization Biosimilars Escalating R&D costs

Reduced R&D staff and budgets Delays in clinical study recruitment New regulations and legislation Heightened regulatory scrutiny Decreasing drug approvals Constrained capital markets Drug development imperatives Targeting large markets Decreasing time to launch Conclusion The continued growth of contract R&D Summary Contract research organizations The role of CROs Services offered by CROs CRO usage, 2010–2016 Global CRO forecasts by phase of drug Global CRO forecasts by world region Drivers of rising CRO usage Vertical integration Risk sharing programs Growth of R&D spending Biotechnology expansion Adaptive trials Technology Restraints inhibiting greater CRO usage Pharma industry consolidation CRO consolidation and competition R&D budget reductions CRO personnel shortages Conclusion Continued demand in the established regions Summary Introduction The US CRO market Overview US CRO usage by phase of drug, 2010–16 The Western European CRO market Overview Western European CRO usage by phase of drug, 2010 – 2016 Conclusion Strong growth in the emerging regions Summary Introduction The Eastern European CRO market Overview Eastern European CRO usage by phase of drug, 2010–16 The Chinese CRO market Overview Chinese CRO usage by phase of drug, 2010–2016 The Indian CRO market Overview Indian CRO usage by phase of drug, 2010–16 The Asian CRO market, exclusive of China and India Overview Other Asian CRO usage by phase of drug, 2010 – 2016 The Latin American CRO market Overview Latin American CRO usage by phase of drug, 2010 – 2016

Leading global CROs and best practices Summary Introduction Leading players Quintiles Covance PPD Charles River Laboratories PAREXEL International ICON Ricerca Kendle/INC Research PRA International WuXi AppTec PharmaNet/inVentiv Case studies Employee retention: Quintiles Service expansion: Covance Service innovation: PAREXEL Global expansion: ICON plc Vertical integration:WuXi AppTec Conclusion The future of contract research Summary Introduction The drug development landscape in the US and EU Near term: 2012 – 2013 Long term: 2014 – 2016 R&D outsourcing trends Near term: 2012 – 2013 Long term: 2014 – 2016 Conclusion Appendix Scope Methodology Primary research Secondary research Sources used Glossary/Abbreviations TABLES Table: CDER drug advisory committees, September 2011 Table: Leading European National Competent Authorities, 2011 Table: Revenues and Patent Expirations for Selected Companies’ Blockbusters, 2011 Table: Biosimilars approved in the US and EU, 2010 Table: Expected biosimilar launches in the US and EU Table: Significant R&D Staff Reductions, 2008–11 Table: Patient recruitment requirements by clinical trials phase Table: US New Molecular Entity (NME) Approvals, 2000 - 2010 Table: US New Molecular Entity (NME) Approvals, 1990 - 2010 Table: Leading Medicinal Research Areas, 2011 FIGURES Figure: US NME approvals vs. R&D spend, 1990–2010 Figure: CRO market by drug phase ($bn), 2010 Figure: CRO market by region ($bn), 2010 Figure: Global pharmaceutical R&D spending ($bn), 2002 - 2016 Figure: Global biotech R&D spending ($bn), 2008 - 2016 Figure: CRO fees in the established regions ($bn), 2010–16

Figure: US CRO fees by drug phase ($bn), 2010–16 Figure: Overall indexed clinical trial costs by region, 2006–10 Figure: Leading US CRO market players, 2010 Figure:Western European CRO fees by drug phase ($bn), 2010–16 Figure: Leading Western European CRO market players, 2010 Figure: CRO fees in the emerging regions ($bn), 2010–16 Figure: Clinical trial costs of European countries compared to the UK Figure: Comparison of trial registration periods in Eastern European countries (days) Figure: Eastern European CRO fees by drug phase ($bn), 2010–16 Figure: Leading Eastern European CRO market players, 2010 Figure: Chinese CRO fees by drug phase ($m), 2010–16 Figure: Leading Chinese CRO market players, 2010 Figure: Indian CRO fees by drug phase in $m, 2010–16 Figure: Leading Indian CRO market players, 2010 Figure: Other Asian CRO fees by drug phase in $m, 2010–16 Figure: Leading Other Asian CRO market players, 2010 Figure: Latin American CRO fees by drug phase in $m, 2010–16 Figure: Leading Latin American CRO market players, 2010 Figure: Capabilities of leading global CROs, 2011 Figure: Forces driving and restraining CRO growth in the near and long term

Ordering:

Order Online - http://www.researchandmarkets.com/reports/2013905/ Order by Fax - using the form below Order by Post - print the order form below and send to Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland.

Page 1 of 2 Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-1907 (from USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit http://www.researchandmarkets.com/contact/

Order Information Please verify that the product information is correct and select the format(s) you require. Product Name:

The CRO Market Outlook to 2016

Web Address:

http://www.researchandmarkets.com/reports/2013905/

Office Code:

SC

Product Formats Please select the product formats and quantity you require: Quantity Electronic (PDF) Single User:

USD 3835

Electronic (PDF) Enterprisewide:

USD 14381

* The price quoted above is only valid for 30 days. Please submit your order within that time frame to avail of this price as all prices are subject to change.

Contact Information Please enter all the information below in BLOCK CAPITALS Title: First Name:

Mr

Mrs

Dr

Miss Last Name:

Email Address: * Job Title: Organisation: Address: City: Postal / Zip Code: Country: Phone Number: Fax Number: * Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL)

Ms

Prof

Page 2 of 2 Payment Information Please indicate the payment method you would like to use by selecting the appropriate box. Pay by credit card:

You will receive an email with a link to a secure webpage to enter your credit card details.

Pay by check:

Please post the check, accompanied by this form, to: Research and Markets, Guinness Center, Taylors Lane, Dublin 8, Ireland.

Pay by wire transfer:

Please transfer funds to: Account number

833 130 83

Sort code

98-53-30

Swift code

ULSBIE2D

IBAN number

IE78ULSB98533083313083

Bank Address

Ulster Bank, 27-35 Main Street, Blackrock, Co. Dublin, Ireland.

If you have a Marketing Code please enter it below: Marketing Code: Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to: (646) 607-1907 or (646) 964-6609 - From USA +353-1-481-1716 or +353-1-653-1571 - From Rest of World